BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Prognosis
4 results:

  • 1. Clinicopathological Features and prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
    Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
    Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
    [No Abstract]    [Full Text] [Related]  

  • 2. Evi-1 Influence on Clinical Progress of colorectal cancer Patients.
    Zhu Y; Zhang J; Ye Z; Peng P; Lan X; Xie L; Qin M; Huang J
    Ann Clin Lab Sci; 2020 May; 50(3):354-360. PubMed ID: 32581025
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [colorectal Carcinoma in Young Patients - Is Age a Prognostic Factor?].
    Schellerer V; Croner R; Langheinrich M; Hohenberger W; Merkel S
    Zentralbl Chir; 2015 Dec; 140(6):600-6. PubMed ID: 23846539
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival.
    Holland TA; Elder J; McCloud JM; Hall C; Deakin M; Fryer AA; Elder JB; Hoban PR
    Int J Cancer; 2001 Sep; 95(5):302-6. PubMed ID: 11494229
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.